About US

Driven by advanced regenerative medicine and tissue engineering, DERSMITHSON sp. z o.o. leads the way in developing high-performance aesthetics and medical fillers.

Our mission is to redefine aging and elevate the quality of life through scientific innovation.

= Anti-adhesion anti-cancer
= Biodegradable polyners for DDS systems.
= PLG.PLLA.PDO.PEG.Dextran..Microssphere

Drug loading of microsphere

Sustained release of drug –loaded PLGA microspheres

Controlled drug delivery system

It can release drugs within a consistent concentration range and maintain a steady level of the drug in the bloodstream.

It can reduce the risk of shock caused by a high concentration of the drug after injection.

It can reduce the frequency of drug administration via injection.

A technology designed to maintain drug levels within the therapeutic window, between the maximum safe concentration and the minimum effective concentration
(a key requirement for regulatory clearance)

Fibroin: A complex product of fibroin alpha and beta

Dual-Action Hydration: The Alpha-helix ensures deep moisture delivery, while the Beta-sheet creates a breathable film to lock in hydration and prevent water loss.

Regenerative Support: The hybrid structure acts as a bioactive scaffold that promotes fibroblast proliferation, boosting natural collagen synthesis and skin elasticity.

Skin Barrier Protection: The structural stability of the Beta-sheet shields the skin from environmental stressors, while the biocompatible Alpha-helix soothes irritation.

Superior Sensory Profile: Provides an immediate silky smooth finish and helps refine skin texture by filling in fine lines and irregularitie

Patent

10-1670249 Anticancer Drug Delivery and Manufacturing Method thereof

10-2024-0187809 Hydrogel composition comprising silk fibroin for tissue Regeneration And method of application thereof

10-2025-0160747 Biocompatible Tissue-Engineered Dermal Filler Comprising A Complex of PLA Microspheres and Alpha-Structured Fibroin For Enhanced Skin Regeneration and It's Manufacturing Method.

Dersmithson has researched and developed numerous cosmetic and medical filler etc products through innovative tissue engineering technologies over the past 20 years,
In addition, many patents and technologies were transferred to various companies.